Looking back from 2023, the stock might actually seem cheap today. Here's why.
News & Analysis: Veeva Systems
This healthcare software company plays a pivotal role in the development of new drugs and treatments.
Which of these SaaS titans is more worthy of your investing dollars?
VEEV earnings call for the period ending October 31, 2019.
One is slightly cheaper. The other has a slightly better financial position. But which has a wider moat?
These three companies have a lot going right for them.
The cloud-based software company has driven strong growth by focusing on executing a simple concept well.
Is it time to take advantage of a recent pullback, or is this a falling knife you don't want to catch?
Digital transformation in life sciences will be a long and steady tailwind.
This growth stock has jumped 80% in 2019 -- and still trades at 70 times forward earnings.